CAS 698387-09-6 Neratinib
NAME:Neratinib CAS:698387-09-6 MF:C30H29ClN6O3 MW:557.04 MP:185-187°C DENSITY:1.33 Purity:98% Appearance:solid
Categories:
Life Science Chemicals
Pharmaceutical Intermediates
Email:sale06@alfachem.cn
Product introduction
| PRODUCT NAME | Neratinib |
| CAS NO | 698387-09-6 |
| MF | C30H29ClN6O3 |
| MW | 557.04 |
| MP | 185-187°C |
| DENSITY | 1.33 |
| EINECS | 811-237-1 |
| STORGR | Refrigerator |
| DELIVERY | 2-3DAYS |
| PACKAGE | According client's request |
Description of CAS NO:698387-09-6 Neratinib:
Neratinib is a protein kinase inhibitor used to treat breast cancer that overexpresses the HER2 receptor. It is used to treat patients with HER2-overexpressed or amplified breast cancer that has been previously treated with trastuzumab.
Applications of CAS NO:698387-09-6 Neratinib:
Neratinib in Breast Cancer Treatment
HER2-Positive Breast Cancer : Neratinib is an irreversible inhibitor of the human epidermal growth factor receptors HER1, HER2, and HER4, showing effectiveness primarily in HER2-positive breast cancer treatment. It is approved in the USA for the extended adjuvant treatment of HER2-positive early-stage breast cancer patients who have previously undergone a trastuzumab-based adjuvant regimen
Key words:
Related Products
Related Products
Inquiry